Severe asthma: We’re working to give you more freedom between treatments.
The TPMG Clinical Research Division in Williamsburg is actively recruiting patients for multiple Asthma Studies. The NIMBLE Study is looking at a possible new medicine (study drug) for people with eosinophilic asthma (a type of severe asthma). The study will look at how safe the study drug is and whether it works for adults and adolescents with eosinophilic asthma.
Participation Criteria:
- Must be 18 years of age or older
- Have severe asthma that has been controlled with mepolizumab or benralizumab for at least 12 months.
-
Want to know more? If you are interested in the NIMBLE study, please contact Dawn Bloch, B.S., C.C.R.C., Clinical Research Manager at (757) 707-3503.
